Address
1207 Delaware Ave #1906
Wilmington DE 19806, USA
About the Journal
Health AI Frontier is an international peer-reviewed open access journal dedicated to publishing transformative research at the convergence of artificial intelligence, healthcare technologies, biomedical sciences, clinical innovation, and digital medicine.
The journal serves as a global scholarly platform for researchers, clinicians, healthcare professionals, engineers, data scientists, policymakers, and technology innovators working toward the future of intelligent healthcare systems.
Our Vision
To become a leading global platform advancing the integration of artificial intelligence and healthcare sciences for the development of accessible, intelligent, ethical, and patient-centered medical systems.
AI for Better Health Care
Empowering accessible, ethical, AI-driven healthcare for better patient outcomes worldwide.
Global Scientific Accessibility
Supports worldwide dissemination of healthcare knowledge through open access publishing.
Innovation-Oriented Research
Encourages frontier technologies and transformative healthcare solutions.
Clinical and Translational Relevance
Promotes practical applications improving patient care and healthcare systems.
Technological and Ethical Balance
Supports responsible innovation alongside technological advancement.
High Research Diversity
Welcomes theoretical, experimental, computational, translational, and applied healthcare studies.
Our Journal Scope & Focus Areas
Health AI Frontier covers a wide spectrum of emerging and established domains in healthcare intelligence and biomedical innovation.
Additional Areas of Interest
Why Choose Us
Health AI Frontier is a pioneering open-access journal dedicated to bridging the gap between artificial intelligence and real-world clinical research. We provide a rigorous, collaborative, and globally connected platform for researchers advancing the future of healthcare.
Rigorous Peer Review Process
Every manuscript submitted to our journal undergoes a thorough double-blind peer review conducted by international experts in AI, clinical medicine, and biomedical research — ensuring the highest standards of scientific quality and integrity.
Rapid & Transparent Publication
We are committed to a fast, fair, and fully transparent editorial process. Authors receive timely feedback, clear communication at every stage, and rapid online publication upon acceptance — maximizing the impact and visibility of their work.
Broad Interdisciplinary Scope
Our journal welcomes research spanning artificial intelligence, machine learning, clinical trial design, drug discovery, biomedical data analytics, precision medicine, healthcare informatics, and ethical AI — making it the definitive home for AI-driven clinical research.
Statistical Mistakes That Lead to Rejection
Peer Review in the Age of AI | How Research Is Evaluated Today
AI flooded publishing, editors reject in seconds
Understanding Open Access and APCs — What to Pay, What to Avoid
Journal at a Glance
We are committed to accelerating the pace of AI-driven clinical research by connecting brilliant minds across borders, disciplines, and institutions.
Countries Represented
0
+
Average Review Turnaround
0
Days
Open Access Articles
0
%
Editorial Board & Reviewers
0
+
Editorial Board
We are committed to accelerating the pace of AI-driven clinical research by connecting brilliant minds across borders, disciplines, and institutions.
Dr. Jingkun Chen, PhD
Postdoctoral Researcher at the University of Oxford, England
Dr. Lubna Aziz, PhD
Assistant Professor & Head of Artificial Intelligence, Faculty of Engineering, Science & Technology (FEST), IQRA University, Karachi, Pakistan
Dr. Chitradevi D, ME, PhD
Associate Professor, SRM Institute of Science and Technology, Trichy, India
Dr. H. Lin, PhD
Assistant Professor, The University of Tokyo, Tokyo, Japan
Dr. Hatıra Günerhan
Associate Professor, Department of Mathematics, Kafkas University, Kars, Turkey
Recent Articles
Breast Cancer Diagnosis with Analog Artificial Neural Network: A Survey of Architectures, Implementations, and Challenges
The primary driver of female death remains breast cancer, highlighting the need for effective screening and accessible diagnostic tools...
AI Prediction of the Physicochemical Structural Profile Required for Antitumor Drugs to Cross the Blood Brain Barrier
Effectiveness of chemotherapy treatment for brain-related disorders is primarily limited by the difficulty these drugs have, in crossing the Blood-Brain Barrier (BBB)...
